Resistance to insulin therapy among patients and providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

Mark Peyrot, Richard R. Rubin, Torsten Lauritzen, Soren E. Skovlund, Frank J. Snoek, David R. Matthews, Rüdiger Landgraf, Line Kleinebreil

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

OBJECTIVE - To examine the correlates of patient and provider attitudes toward insulin therapy. RESEARCH DESIGN AND METHODS - Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates of attitudes toward insulin therapy among patients, physicians, and nurses. RESULTS - Patient and provider attitudes differ significantly across countries, controlling for individual characteristics. Patients rate the clinical efficacy of insulin as low and would blame themselves if they had to start insulin therapy. Self-blame is significantly lower among those who have better diet and exercise adherence and less diabetes-related distress. Patients who are not managing their diabetes well (poor perceived control, more complications, and diabetes-related distress) are significantly more likely to see insulin therapy as potentially beneficial. Most nurses and general practitioners (50-55%) delay insulin therapy until absolutely necessary, but specialists and opinion leaders are less likely to do so. Delay of insulin therapy is significantly less likely when physicians and nurses see their patients as more adherent to medication or appointment regimens, view insulin as more efficacious, and when they are less likely to delay oral diabetes medications. CONCLUSIONS - Patient and provider resistance to insulin therapy is substantial, and for providers it is part of a larger pattern of reluctance to prescribe blood glucose-lowering medication. Interventions to facilitate timely initiation of insulin therapy will need to address factors associated with this resistance.

Original languageEnglish
Pages (from-to)2673-2679
Number of pages7
JournalDiabetes Care
Volume28
Issue number11
DOIs
Publication statusPublished - 1 Dec 2005

Cite this

Peyrot, Mark ; Rubin, Richard R. ; Lauritzen, Torsten ; Skovlund, Soren E. ; Snoek, Frank J. ; Matthews, David R. ; Landgraf, Rüdiger ; Kleinebreil, Line. / Resistance to insulin therapy among patients and providers : Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. In: Diabetes Care. 2005 ; Vol. 28, No. 11. pp. 2673-2679.
@article{99bb76f5b16144b5a12e9f73f5259a31,
title = "Resistance to insulin therapy among patients and providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study",
abstract = "OBJECTIVE - To examine the correlates of patient and provider attitudes toward insulin therapy. RESEARCH DESIGN AND METHODS - Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates of attitudes toward insulin therapy among patients, physicians, and nurses. RESULTS - Patient and provider attitudes differ significantly across countries, controlling for individual characteristics. Patients rate the clinical efficacy of insulin as low and would blame themselves if they had to start insulin therapy. Self-blame is significantly lower among those who have better diet and exercise adherence and less diabetes-related distress. Patients who are not managing their diabetes well (poor perceived control, more complications, and diabetes-related distress) are significantly more likely to see insulin therapy as potentially beneficial. Most nurses and general practitioners (50-55{\%}) delay insulin therapy until absolutely necessary, but specialists and opinion leaders are less likely to do so. Delay of insulin therapy is significantly less likely when physicians and nurses see their patients as more adherent to medication or appointment regimens, view insulin as more efficacious, and when they are less likely to delay oral diabetes medications. CONCLUSIONS - Patient and provider resistance to insulin therapy is substantial, and for providers it is part of a larger pattern of reluctance to prescribe blood glucose-lowering medication. Interventions to facilitate timely initiation of insulin therapy will need to address factors associated with this resistance.",
author = "Mark Peyrot and Rubin, {Richard R.} and Torsten Lauritzen and Skovlund, {Soren E.} and Snoek, {Frank J.} and Matthews, {David R.} and R{\"u}diger Landgraf and Line Kleinebreil",
year = "2005",
month = "12",
day = "1",
doi = "10.2337/diacare.28.11.2673",
language = "English",
volume = "28",
pages = "2673--2679",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "11",

}

Resistance to insulin therapy among patients and providers : Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. / Peyrot, Mark; Rubin, Richard R.; Lauritzen, Torsten; Skovlund, Soren E.; Snoek, Frank J.; Matthews, David R.; Landgraf, Rüdiger; Kleinebreil, Line.

In: Diabetes Care, Vol. 28, No. 11, 01.12.2005, p. 2673-2679.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Resistance to insulin therapy among patients and providers

T2 - Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

AU - Peyrot, Mark

AU - Rubin, Richard R.

AU - Lauritzen, Torsten

AU - Skovlund, Soren E.

AU - Snoek, Frank J.

AU - Matthews, David R.

AU - Landgraf, Rüdiger

AU - Kleinebreil, Line

PY - 2005/12/1

Y1 - 2005/12/1

N2 - OBJECTIVE - To examine the correlates of patient and provider attitudes toward insulin therapy. RESEARCH DESIGN AND METHODS - Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates of attitudes toward insulin therapy among patients, physicians, and nurses. RESULTS - Patient and provider attitudes differ significantly across countries, controlling for individual characteristics. Patients rate the clinical efficacy of insulin as low and would blame themselves if they had to start insulin therapy. Self-blame is significantly lower among those who have better diet and exercise adherence and less diabetes-related distress. Patients who are not managing their diabetes well (poor perceived control, more complications, and diabetes-related distress) are significantly more likely to see insulin therapy as potentially beneficial. Most nurses and general practitioners (50-55%) delay insulin therapy until absolutely necessary, but specialists and opinion leaders are less likely to do so. Delay of insulin therapy is significantly less likely when physicians and nurses see their patients as more adherent to medication or appointment regimens, view insulin as more efficacious, and when they are less likely to delay oral diabetes medications. CONCLUSIONS - Patient and provider resistance to insulin therapy is substantial, and for providers it is part of a larger pattern of reluctance to prescribe blood glucose-lowering medication. Interventions to facilitate timely initiation of insulin therapy will need to address factors associated with this resistance.

AB - OBJECTIVE - To examine the correlates of patient and provider attitudes toward insulin therapy. RESEARCH DESIGN AND METHODS - Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates of attitudes toward insulin therapy among patients, physicians, and nurses. RESULTS - Patient and provider attitudes differ significantly across countries, controlling for individual characteristics. Patients rate the clinical efficacy of insulin as low and would blame themselves if they had to start insulin therapy. Self-blame is significantly lower among those who have better diet and exercise adherence and less diabetes-related distress. Patients who are not managing their diabetes well (poor perceived control, more complications, and diabetes-related distress) are significantly more likely to see insulin therapy as potentially beneficial. Most nurses and general practitioners (50-55%) delay insulin therapy until absolutely necessary, but specialists and opinion leaders are less likely to do so. Delay of insulin therapy is significantly less likely when physicians and nurses see their patients as more adherent to medication or appointment regimens, view insulin as more efficacious, and when they are less likely to delay oral diabetes medications. CONCLUSIONS - Patient and provider resistance to insulin therapy is substantial, and for providers it is part of a larger pattern of reluctance to prescribe blood glucose-lowering medication. Interventions to facilitate timely initiation of insulin therapy will need to address factors associated with this resistance.

UR - http://www.scopus.com/inward/record.url?scp=33644798145&partnerID=8YFLogxK

U2 - 10.2337/diacare.28.11.2673

DO - 10.2337/diacare.28.11.2673

M3 - Article

VL - 28

SP - 2673

EP - 2679

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 11

ER -